Operating executive and investor focused on growth-stage healthcare and technology companies, Kathryn Lutz brings cross-functional experience in corporate strategy, M&A integration and scaling commercial operations. Works with boards and PE sponsors to drive margin expansion, EBITDA growth and go-to-market acceleration. Prior experience spans strategic roles at mid-market healthcare services firms and growth-stage tech companies; holds an MBA and is active as an independent director and advisor to venture and buyout funds.
Operating executive and investor focused on growth-stage healthcare and technology companies, Kathryn Lutz brings cross-functional experience in corporate strategy, M&A integration and scaling commercial operations. Works with boards and PE sponsors to drive margin expansion, EBITDA growth and go-to-market acceleration. Prior experience spans strategic roles at mid-market healthcare services firms and growth-stage tech companies; holds an MBA and is active as an independent director and advisor to venture and buyout funds.
Growth-stage healthcare and technology investor with a hands-on, operationally driven approach to capital allocation. Prioritizes businesses where commercial scale, margin expansion and EBITDA conversion can be accelerated through go-to-market optimization, strategic M&A and rigorous operational KPIs. Favors control or influential minority positions alongside PE sponsors and boards, with a medium-term horizon focused on scalable revenue and margin uplift. Risk discipline centers on validated unit economics, repeatable sales motion and executable integration plans.
Growth-stage healthcare and technology investor with a hands-on, operationally driven approach to capital allocation. Prioritizes businesses where commercial scale, margin expansion and EBITDA conversion can be accelerated through go-to-market optimization, strategic M&A and rigorous operational KPIs. Favors control or influential minority positions alongside PE sponsors and boards, with a medium-term horizon focused on scalable revenue and margin uplift. Risk discipline centers on validated unit economics, repeatable sales motion and executable integration plans.
| Trades 1864 | Longs Won 1102/1864 59% | Profit Factor 14.9 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $118,943.43 |
| Average Win $24,800.05 | Best Trade (Jul 17) $2.92M | Sharpe Ratio -9.19 |
| Average Loss -$2,406.32 | Worst Trade (Jul 17) -$138,840.32 | Z-Score -2.32 (100%) |
| Commissions $0 | Avg. Trade Length 10m 2w 1d | Expectancy $13,678.13 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 38,462 | 34,615 | 30,769 | 26,923 | 23,077 | 19,231 | 15,385 | 11,538 | 7,692 | 3,846 |